Skip to main content
Virulence logoLink to Virulence
. 2018 May 4;9(1):818–836. doi: 10.1080/21505594.2018.1451184

Extracellular vesicles and vesicle-free secretome of the protozoa Acanthamoeba castellanii under homeostasis and nutritional stress and their damaging potential to host cells

Diego de Souza Gonçalves a, Marina da Silva Ferreira b, Susie Coutinho Liedke b, Kamilla Xavier Gomes a, Gabriel Afonso de Oliveira a, Pedro Ernesto Lopes Leão c, Gabriele Vargas Cesar c, Sergio H Seabra d, Juliana Reis Cortines e, Arturo Casadevall f, Leonardo Nimrichter c, Gilberto Barbosa Domont g, Magno Rodrigues Junqueira g, Jose Mauro Peralta b, Allan J Guimaraes a,
PMCID: PMC5955443  PMID: 29560793

ABSTRACT

Acanthamoeba castellanii (Ac) are ubiquitously distributed in nature, and by contaminating medical devices such as heart valves and contact lenses, they cause a broad range of clinical presentations to humans. Although several molecules have been described to play a role in Ac pathogenesis, including parasite host-tissue invasion and escaping of host-defense, little information is available on their mechanisms of secretion. Herein, we describe the molecular components secreted by Ac, under different protein availability conditions to simulate host niches. Ac extracellular vesicles (EVs) were morphologically and biochemically characterized. Dynamic light scattering analysis of Ac EVs identified polydisperse populations, which correlated to electron microscopy measurements. High-performance thin liquid chromatography of Ac EVs identified phospholipids, steryl-esters, sterol and free-fatty acid, the last two also characterized by GC-MS. Secretome composition (EVs and EVs-free supernatants) was also determined and proteins biological functions classified. In peptone-yeast-glucose (PYG) medium, a total of 179 proteins were identified (21 common proteins, 89 exclusive of EVs and 69 in EVs-free supernatant). In glucose alone, 205 proteins were identified (134 in EVs, 14 common and 57 proteins in EVs-free supernatant). From those, stress response, oxidative and protein and amino acid metabolism proteins prevailed. Qualitative differences were observed on carbohydrate metabolism enzymes from Krebs cycle and pentose phosphate shunt. Serine proteases and metalloproteinases predominated. Analysis of the cytotoxicity of Ac EVs (upon uptake) and EVs-free supernatant to epithelial and glioblastoma cells revealed a dose-dependent effect. Therefore, the Ac secretome differs depending on nutrient conditions, and is also likely to vary during infection.

KEYWORDS: Acanthamoeba castellanii, exosomes, pathogenesis, secretome, virulence factors

Introduction

Protozoa from the genus Acanthamoeba have been isolated from distinct environments around the world, such as soil, water reservoirs, public toilets or environmental water sources, such as lakes and rivers [1,2]. Medical devices, i.e., heart valves [3] and contact lenses, are also platforms for the growth of Acanthamoeba sp.; the last mainly by the usage of contaminated cleaning solutions [4–6].

The Acanthamoeba genus is comprised of single-celled microorganisms, which features two distinct phases of life cycle: the free-living and metabolically active stage trophozoites and the resistant phase stage called cyst. The parasitic trophozoites are motile and display spiny-like projections on their surfaces, called acanthapodia. These movements are important for Acanthamoeba nutrient acquisition, which happens essentially by phagocytosis of bacteria or yeasts. On the other hand, the non-motile cyst form has a double-layered wall, which provides resistance to environmental adversities such as extremes of pH, high temperatures and antimicrobials [6–9].

Acanthamoeba sp. infections are associated with a broad range of clinical presentations in humans, but the most common conditions involve the eye and central nervous system infections [6,10–12]. Acanthamoeba keratitis is one of the most common and serious clinical manifestations caused by this organism, followed by encephalitis; both can cause irreversible damage if not treated properly [10,11,13–15].

Several molecules have been described to have a role on Acanthamoeba pathogenesis, helping the protozoa to invade the host tissue and escape their defense mechanisms [16,17]. The secretion of glycoproteins, proteases and others molecules was correlated with the pathogenic potential of these organisms [18]. Among these components, proteases have been documented as the major virulence factors and could mediate host tissue destruction and digestion of phagocytosed particles within the microorganism [19–21]. In addition to the effects of proteases such as elastases, metalloproteases, serine and cysteine proteases regarding tissue invasion [21–26], they are also directly related to mannose-binding proteins mediated adhesion, playing important role in the interaction of Acanthamoeba and the host cell.

In recent years, extracellular vesicles (EVs) have been described as secretion mechanisms for a wide range of molecules to reach the extracellular environment in a large number of organisms [27–31]. The cellular origin of these vesicular molecules and the exact mechanism by which they are produced are yet to be determined, although numerous studies suggest that this process involves components of both conventional and non-conventional secretion pathways [32–34]. However, morphological and biochemical characteristics indicate that they are similar to those described in several mammalian cells [35], containing lipids, nucleic acids, protein and polysaccharide components [31,36–38]. In the case of important human fungal pathogens, many of those components are associated with virulence [33,36,37,39,40].

The production of EVs have also been described in such protozoa as Plasmodium sp [41]., Leishmania donovani and L. major [42,43], Trypanosoma brucei [44,45], T. cruzii [46,47], in helmints such as the nematodes Echinostoma caproni and Fasciola hepatica [48], Helingmosomoides polygrus [49], Teladorsagia circumcincta [50], the trematode Dicrocoelium dendriticum [51] and the amoeba Dictyostelium discoideum [52]. Some reports have stated the importance of these exosomes during host-parasite interaction, working as communication mediators between the different cells from distinct organisms, therefore bearing a potential therapeutic target for infectious diseases [40,41].

The secretory mechanisms used by amoebas are still unclear, but there is a parallel to the release of exosomes described in eukaryotes such as parasites, fungi and mammals [53–56]. In these models, EVs have been described to be involved in the secretion of proteinases into the extracellular environment, with important implications for the pathogenesis and virulence [18,40,41,57]; EVs from Acanthamoeba sp. may contain important virulence factors which, when secreted, could also damage host tissues. Our goal in this study was to characterize the EVs produced and secreted by A. castellanii. As this organism can be found, either within the host or in the environment, in several locations with the most diverse protein concentrations, we characterized the secretome profile of A. castellanii, including the isolation EVs and EV-free fractions, in conditions of distinct availability of protein sources. As EVs were taken up by host cells, the damaging potential and lethal activity of EVs and EVs-free supernatant to host cells were evaluated. Our results suggest the participation of the secretome of A. castellanii on pathogenesis, which could provide a new option for the therapeutic interventions of A. castellanii infections.

Results

A. castellanii trophozoites shed membrane vesicles

Scanning electron microscopy of A. castellanii grown in PYG medium revealed the presence of membrane bound vesicles of circular shape and distinct sizes, composing a polydisperse population, as a result of evagination from the extracellular membrane (Figure 1A). The dimensions of these structures closely approximate dimensions of EV reported for many microorganisms.

Figure 1.

Figure 1.

Characterization of EVs secreted by A. castellanii (A) Scanning microscopy of A. castellanii demonstrating the ultrastructure and topography of the amoeba. At the cell´s surface, it is possible to visualize the vesicle shedding, with evagination from the membrane of sphere-like structures. (B and C) Negative contrastation and diameter measurement of EVs secreted by A. castellanii isolated from (B) PYG (PYG-EVs, average diameter of 117.1 ± 73.3 nm as indicated by the axis thick and gray dashed line) and (C) glucose (glucose-EVs, average diameter of 117.7 ± 55.8 nm indicated by axis thick and gray dashed line) medium. On images (B and C), solid black arrows indicate the presence of nano-EVs (<50 nm); open arrows the presence of EVs ranging from 50–200 nm and white arrows, a population of large EVs (>200 nm). Displayed results are the average of 2 independent experiments.

A. castellanii produces distinct vesicle populations depending on growth conditions

A. castellanii was grown in two distinct conditions, under ATCC recommended culture medium (712 PYG) and in media without any protein source (glucose medium), to recapitulate the nutritional stress undergone by A. castellanii in the aqueous and vitreous humor in vivo. After negative staining of EVs from both culture conditions, they were evaluated by transmission electron microscopy, and the dimensions of EVs measured. A. castellanii EVs from PYG medium (PYG-EVs) displayed a diameter ranging from 31.9 to 467 nm (picture inset, Figure 1B), with an average diameter of 117.1 ± 73.3 nm (Figure 1B; axis thick and gray dashed line). EVs obtained from A. castellanii grown in glucose medium (glucose-EVs) ranged from 33.7 to 303.2 nm (picture inset, Figure 1C), with an average diameter of 117.7 ± 55.8 nm (Figure 1C, axis thick and gray dashed line). Despite similar diameter averages at both growth conditions (p > 0.05), EVs from A. castellanii grown in PYG medium consisted in a more diverse population.

Dynamic light scattering displays polydispersity in extracellular vesicle populations depending on medium composition

To confirm the results discussed above, we measured the size of larger number of EVs using dynamic light scattering (DLS) and their diameters were compared. PYG-EVs in solution displayed three major populations, 56.1 to 68.4 nm, 150.4 to 223.0 nm and 402.9 to 659.4 nm (total average of 287.7 ± 154.8 nm, Figure 2A). Glucose-EVs instead, displayed only two populations, with diameters ranging from 173.2 to 234.8 nm and from 585.1 to 746.5 nm (total average of 365.1 ± 224.6 nm, Figure 2B), slightly larger than EVs obtained from growth in PYG (p>0.05).

Figure 2.

Figure 2.

Characterization of the EVs’ populations secreted by A. castellanii by dynamic light scattering (DLS). The graphs are representative of the two replicates displaying similar results. EVs secreted and isolated from A. castellanii grown in (A) PYG (PYG-EVs, total average of 287.7 ± 154.8 nm, black arrow and gray dashed line) and (B) glucose medium (glucose-EVs, total average of 365.1 ± 224.6 nm, black arrow and gray dashed line). (C and D) Correlation of the diameters obtained by electron microscopy and DLS of EVs isolated from A. castellanii grown in (C) PYG (PYG-EVs) and (D) glucose medium (glucose-EVs). Open circles (○) indicates EVs populations identified in only one of the size measurement methodology, whereas closed circles (•) indicates EVs populations identified in both methods.

EVs diameters by microscopy and DLS were compared and correlated. PYG-EVs measurements by both methodologies significantly correlated (r = −0.53 and p = 0.022, Figure 2C), as common measurements were observed for the three populations identified. As for PYG, microscopy and DLS measurements of glucose-EVs correlated significantly (r = −0.44 and p = 0.040, Figure 2D), despite the lower number of equivalences among the total populations when compared to PYG-EVs, with common specimens detected for size populations around 200 nm.

Lipid composition of A. castellanii extracellular vesicles

Total lipids extracted from A. castellanii EVs were qualitatively evaluated by high performance thin layer chromatography (HPTLC), (Figure 3A). Results shown are representative of 2 biological replicates (performed in duplicate). PYG-EVs of A. castellanii, displayed the presence of phospholipids, sterol, free fatty acid and steryl esters. Glucose-EVs displayed similar constitution, except for the absence of free fatty acids.

Figure 3.

Figure 3.

Evaluation of neutral lipid composition of EVs. (A) High performance thin liquid chromatography for neutral lipids of the EVs from Acanthamoeba castellanii. Lane 1 – Lipid standards (TG- Triglycerides −; DAG- Diacylglycerol; MAG- Monoacylglycerol), Lane 2- EVs secreted in PYG, Lane 3- EVs secreted in glucose medium and Lane 4- Lipid standards (EC- Esterified cholesterol; FFA- Free fatty acids; S- cholesterol; PL/O- Phospholipids. (B) GC-MS for determination of sterol composition in EVs of A. castellanii. Two biological replicates were analyzed with similar results. Peaks of interest are represented by numerals, followed by their retention time in the chromatogram. Peak 1 – [(3-β)-cholest-5-en-3-yl]oxy]trimethyl]-silane (rt = 32.557 min), Peak 2 – [(ergosta-5,7,22-trien-3β-yloxi)trimethyl]-silane (rt = 35.355 min) and Peak 3 -stigmasta-5,7,22-trien-3α-ol (rt = 35.520 min). (C) GC-MS for fatty acids present in the EVs of A. castellanii. Peaks of interest are represented by numerals, followed by their retention time in the chromatograph. Peak 1- methyl miristate (rt = 20.663 min), Peak 2- methyl palmitate (rt = 32.008 min), Peak 3- methyl linoleate (rt = 44.200 min), Peak 4- methyl oleate (rt = 44.683 min), Peak 5- methyl stearate (rt = 46.675 min) of and Peak 6- methyl erucate (rt = 75.033 min).

Since the lipid evaluation of PYG-EVs showed a more complex composition, we submitted this sample to GC-MS for the characterization of the sterol and free fatty acids species. Regarding sterol analysis, three major peaks were identified according to their retention time and MS fragmentations (Figure 3B and Supplemental figure 1A-C). Peak 1 was representative of a [(3-β)-cholest-5-en-3-yl]oxy]trimethyl]-silane (retention time(rt) = 32.557 min), whereas peak 2 was characteristic of a [(ergosta-5,7,22-trien-3β-yloxi)trimethyl]-silane (rt = 35.355 min) and peak 3, a stigmasta-5,7,22-trien-3α-ol (rt = 38.520 min). Regarding free fatty acids analysis, six major peaks were identified (Figure 3C and Supplemental figure 1D-I). Peak 1 (rt = 20.663 min) was characteristic of methyl myristate, peak 2 (rt = 32.008 min) of methyl palmitate, peak 3 (rt = 44.200 min) of methyl linoleate, peak 4 (rt = 44.683 min) of methyl oleate, peak 5 (rt = 46.675 min) of methyl stearate and peak 6 (rt = 75.033 min) of methyl erucate.

Mass spectrometry data analysis and protein identification

EVs and EVs-free supernatant from either PYG or glucose were evaluated by mass spectrometry. The proteins identified in each of three biological replicate (samples 1–3) were analyzed using a Venn diagram to find the number of common proteins in each condition/ fraction. In PYG-EVs, 110 proteins were common in the three replicates (Supplementary Figure 2A), whereas 90 proteins were common in the three replicates of PYG-EVs-free supernatant (Supplementary Figure 2B). For glucose-EVs, 148 common proteins were found in the three replicates (Supplementary Figure 2C), and 71 proteins found for glucose-EVs-free supernatant (Supplementary Figure 2D). The Supplementary Figure 2E displays in each fraction, the number of total proteins identified summing the three replicates (100% in all cases), the number of common proteins identified in at least 2 samples (light colors) and common to the three biological replicates (dark colors). These common proteins in the triplicates of each individual fraction/ condition were used for cross comparison of the secretome fractions (EVs and EVs-free supernatants) of A. castellanii under rich (PYG) or nutritional stress (glucose medium). Considering the total secretome (EVs and EVs-free supernatants), a comparison between the two nutritional conditions was also performed.

Secretome of A. castellanii under rich nutritional conditions

PYG-EVs (110 proteins, as shown in Supplementary Figure 2A) and PYG-EVs-free supernatant proteins (90 proteins, as shown in Supplementary Figure 2B) identified proteins were grouped according to their functional class (www.uniprot.org) and compared. In PYG medium, a total of 179 unique proteins were identified by MS, with 89 proteins (49.7%) exclusively present in the PYG-EVs fraction, 69 proteins (38.5%) exclusively present in the PYG-EVs-free supernatant, and 21 proteins (11.7%) identified in both fractions (Figure 4A and Supplementary Table 1). The majority of proteins in both PYG-EVs and PYG-EVs-free supernatant belonged to the miscellaneous (14 vs. 16, respectively) and unidentified protein classes (17 vs. 18; Figure 4B). Comparing both fractions, proteins related to locomotion (4), cellular stress (2), nucleus (4) and ribosomal proteins (34) were found exclusively in the PYG-EVs. Furthermore, proteins related to cytoskeleton (EVs 10 vs. 2 EVs-free supernatant), structural membrane components (4 vs. 2), protein and amino acid metabolism (8 vs. 2), energetic metabolism (4 vs. 1) and signaling (7 vs. 3) were enriched in the PYG-EVs. Remarkably, the vast majority of proteases were found in the PYG-EVs-free supernatant (12), from which one was also detected in PYG-EVs. Also, proteins related to carbohydrate (3 vs. 13), nucleotide metabolism (2 vs. 6) and oxidative metabolism (2 vs. 5) were mostly present in the PYG-EVs-free supernatant.

Figure 4.

Figure 4.

Identification and grouping of proteins in the secretome of A. castellanii grown in PYG (A and B) and under stress condition (glucose medium, C and D). (A) Venn diagram of the PYG secretome, comparing PYG-EVs (110 proteins) and PYG-EVs-free supernatant (90 proteins, from Supplementary Figure 2 A and B, respectively). From the 179 unique proteins identified, PYG-EVs exclusive proteins (89; 49,7%) are shown in red; proteins identified only in the EVs-free supernatant (69; 38.5%) are shown in yellow, and common proteins of both fractions are shown in orange (21; 11.7%) (B) Number of proteins identified exclusively in PYG-EVs are shown as red bars, whereas the number of proteins only in the EVs-free supernatant are shown in yellow and the number of proteins found in both fractions are shown in orange. (C) Venn diagram of glucose medium secretome, comparing glucose-EVs (148 proteins) and PYG-EVs-free supernatant (71 proteins, from Supplementary Figure 2 C and D, respectively), totalizing 205 unique proteins identified under nutritional stress (glucose medium). The number of proteins identified exclusively in glucose-EVs are shown in blue (134; 65.4%); proteins identified only in the glucose-EVs-free supernatant are shown in gray (57; 27.8%), and common proteins of both fractions are shown in light blue (14; 6.8%). (D) Number of proteins identified from each specific class exclusively in glucose-EVs are shown as blue bars, whereas number of proteins identified only in the glucose-EVs-free supernatant are shown in gray and number of common proteins are shown in light blue. Proteins identified in EVs, EVs-free supernatant or commonly present in both fractions from either PYG or glucose medium, and the class they belonged, are discriminated in Supplementary Tables 1 and 2, respectively.

Proteins secreted by A. castellanii under nutritional stress

Glucose-EVs (148 proteins as shown in the Supplementary Figure 2 C) and Glucose-EVs-free supernatant (71 proteins, as shown in the Supplementary Figure 2 C) fractions of the secretome of A. castellanii were also compared. From the total of 205 unique proteins, 134 (65.4%) were present exclusively in glucose-EVs, 57 proteins (27.8%) were detected only in glucose-EVs-free supernatant and 14 proteins (6.8%) were shared by both fractions (Figure 4C and Supplementary Table 2). As observed with the proteome under rich nutritional conditions, the majority of EVs and EVs-free supernatant secreted proteins by A. castellanii under stress belonged to miscellaneous (35 vs. 12, respectively) and unidentified protein classes (18 vs. 6; Figure 4D). Comparing both fractions, proteins related to structural membrane components (4), locomotion (4) and signaling (3) were found exclusively in the glucose-EVs fraction. Proteins from cytoskeleton (10 vs. 6), protein and amino acid metabolism (16 vs. 6), lipid metabolism (7 vs. 1), nucleotide metabolism (4 vs. 1), nucleus (3 vs. 2) were predominantly present in glucose-EVs fractions after A. castellanii growth under nutritional stress. As in PYG medium, proteins related to the metabolism of carbohydrate (4 vs. 15) and proteases (4 vs. 7) were mostly enriched in the glucose-EVs-free supernatant. Regarding ribosomal proteins, the vast majority was found in EVs (22), and one common protein within the two fractions.

Comparison of A. castellanii secretome in PYG and nutritional stress conditions

The total secretome (EVs + EVs-free supernatant) under each specific growth conditions was compared (PYG 179 proteins and glucose 205 proteins), with 127 proteins (38.3%) exclusively expressed in the PYG secretome, 153 proteins (46.1%) exclusively expressed in glucose secretome and a total of 52 proteins (15.7%) were commonly identified (Supplementary Figure 7A). In the A. castellanii secretome under stress conditions, there were a higher number of proteins involved in protein and amino acid (PYG 10 vs. 22 glucose) and oxidative metabolism (6 vs. 16, respectively), as well as proteins related to cellular stress (1 vs. 3; Supplementary Figure 7B). However, proteins involved in locomotion (3 vs. 1) and signaling (10 vs. 3) were mostly present when A. castellanii was grown under abundance of protein sources.

Secretome and carbohydrate metabolism regulation in A. castellanii

Despite the similarity in the carbohydrate sources in both A. castellanii growth conditions and the overall undistinguishable number of proteins related to carbohydrate metabolism (PYG 16 vs. 18 in glucose alone, with 3 proteins commonly detected; Supplemental Figure 3A), we explored the qualitative differences on carbohydrate usage in both conditions, considering the total secretome (EVs and EVs-free supernatant). A metabolic map displaying the carbohydrate metabolism enzymes detected was constructed (Supplementary Figure 3C).

In both conditions, glycosyl hydrolase was the most prevalent class, with one common entity, as they were involved in the utilization of complex sugar sources. Besides, an α-amylase and the glycolytic pathway enzyme enolase were commonly expressed under the two growth conditions. Exclusively in the secretome of PYG, the enzymes β-glucosidase, β-galactosidase, xylosidase, α- and β-mannosidase were identified and involved in the breakdown of complex sugars. Specifically in glucose medium, proteins such α-1,4-glucan phosphorylase and glucan (α-1,4) branching enzyme were identified. Yet in glucose medium, enzymes from glycolysis, such as glucose-6-phosphate isomerase and triose phosphate isomerase were identified. Enzymes involved in the metabolism of phosphoenol pyruvate (PEP), PEP carboxylase and PEP carboxykinase were also identified, along with two malate dehydrogenase enzymes from the Krebs. In this condition, a transaldolase enzyme involved in the pentose-phosphate pathway, was also observed.

Secretome of A. castellanii and protease identification

The proteases indentified in the EVs and EVs-free supernatant of both growth conditions were grouped into five mains classes as shown in Supplementary table 3. No statistical differences were observed between both growth conditions (p>0.05). However, considering all instances, serine proteases was the most abundant class (9), followed by metalloproteases (6), aspartic proteases (2) and cystein proteases (1). To further confirm the entities from these classes, EVs and EVs-free supernatant were analyzed by gel electrophoresis and their protease activity determined, as the classes of proteases function better at specific ranges of pHs (serine proteases ≥7.0, metallo ≥7.0, 3.0≤ aspartic ≤ 5.0, cysteine ≥7.0) [58]. For all the fractions characterized, protease activity was observed at all pHs tested; however the vast majority of proteins and highest activity was observed at pH 9.0, due to optimum conditions for serine, metallo and cysteine protease activity, being the first two the most abundant protease classes found (Supplemental Figure 4).

EVs are readily taken up by mammalian cells

To verify whether the EVs from A. castellanii could be recognized by the host, these membranous compartments were stained with DilC18 (1,1'-Dioctadecyl-3,3,3', 3'-Tetramethylindocarbocyanine Perchlorate) and given to the mammalian cells. This lipophilic dye intercalates into the membrane phospholipid bilayer, and has been used to label EVs in several instances [31,59,60]. Binding and internalization of EVs of A. castellanii by CHO (epithelial lineage) or T98G (glial lineage) cells were evaluated by confocal microscopy followed by deconvolution analysis. For CHO cells, after 15 min of contact, EVs could be found in association to the cell membrane (Figure 5, second row), as the red-fluorescent DiI C18 labeled EVs co-localized to the green fluorescent CtxB, which labels GM1, indicating the involvement of host cells lipid raft in the EVs cell internalization (Figure 5, second row, merged images). After 30 min of exposure, CHO cells displayed more cell membrane-associated EVs (Figure 5, third row). Following 45 min, EVs could still be found in association to CHO cell membranes or randomly distributed in the cytoplasm (Figure 5, forth row). After 1 h, vesicles were completely internalized and disseminated through the cytoplasm (Figure 5, last row).

Figure 5.

Figure 5.

CHO epithelial cells internalization of EVs from A. castellanii. EVs were stained with DiI C18 (red-stained) and incubated with the CHO for different time points. CHO nuclei were stained with DAPI (blue) and the CtxB- Alexa 488 (green) was used to stain the GM1 ganglioside, a lipid raft marker located on the cell membrane. A. castellanii EVs (DiIC18 red labeled) co-localized with the lipid rafts, suggesting association of GM1 on the CHO internalization of EVs. At early time points, EVs can be found in association to the plasma membrane of CHO cells; at 1 h, EVs seem to be distributed or disseminated through the cytoplasm of CHO cells. Results are representative of at least 10 different fields.

For T98G cells (Figure 6), the kinetics of A. catellanii EVs association followed a similar pattern as observed for CHO cells, with T98 cell membrane-associated EVs at 15 min and 30 min (Figure 6, second and third rows, respectively) and EVs distributed through the cytoplasm at 45 min (Figure 6, forth row). However, after 1 h, vesicles were still compartmentalized within the cytoplasm of T98G cells (Figure 6, last row).

Figure 6.

Figure 6.

T98G glioblastoma cells internalization of EVs from A. castellanii. EVs were stained with DiI C18 (red-stained) and incubated with the CHO for different time points. T98G nuclei were stained with DAPI (blue) and the CtxB- Alexa 488 (green) was used to stain the GM1 ganglioside, a lipid raft marker located on the cell membrane. A. castellanii EVs co-localized with the lipid rafts, suggesting association of GM1 on the T98G internalization of EVs. At early time points, EVs are associated to the membrane of T98G cells; at 1 h, EVs seems to be randomly distributed through the cytoplasm of T98G cells. Results are representative of at least 10 different fields.

A. castellanii secretome toxicity to mammalian cells is dependent on protease activity

Due to ability of CHO and T98G cells to uptake EVs and the presence of several potential virulence factors in the secretome of A. castellanii, their effects on mammalian cells were tested (Figure 7). Controls with BSA, PYG, irrelevant or disrupted A. castellanii EVs had no effect on either CHO or T98G cells viability. For CHO cells, a dose-dependent effect of EVs was observed, with cell viability of 28% when 20 µg/mL was used, and cytotoxic effect observed with concentrations as low as 2.5 µg/mL (73% viability, Figure 7A). EVs-free supernatant also demonstrated a dose-dependent effect, with 8.9% viability at 20 µg/mL and cytotoxic effects with concentrations as low as 2.5 µg/mL (50% viability; Figure 7B). In both cases, inhibition of proteases with subclass specific protease inhibitors protected the cells against the damaging activity of both EVs and EVs-free supernatant.

Figure 7.

Figure 7.

Effects of A. castellanii secretome on viability of mammalian cells. Cells were incubated with decreasing concentrations of A. castellanii secretome (from 20 to 0.010 µg/mL, expressed in total protein content). Cell viability was calculated by the ratio of absorbances of (treated cells)/(untreated negative control). (A-B) Cell viability of CHO cells determined by the MTT assay upon 6 h incubation with (A) EVs and (B) EVs-free supernatant (symbols and solid lines). (C-D) Cell viability of T98G cells determined upon 6 h incubation with (A) EVs and (B) EVs-free supernatant (symbols and dashed lines). PMSF- serine protease inhibitor, phenantroline – metalloprotease inhibitor, pepstatin A- aspartic protease inhibitor, E-64- cystein protease inhibitor and cocktail – complete mini-tabs (Sigma-Aldrich). *p < 0.05.

For glioblastoma T98G cells, EVs also induced a dose-dependent effect on cell viability, with viability dropping to 8.8% at concentrations of 20 µg/mL and cytotoxicity observed with concentrations higher than 0.625 µg/mL (74% viability, Figure 7C). EVs-free supernatants caused a viability reduction to 22% at concentrations of 20 µg/mL, with a little increase to 53% viability when concentrations of 2.5 µg/mL were used (Figure 7D). For these T98 cells, inhibition of proteases also protected the cells against damage.

Apoptosis/necrosis of mammalian cells after exposure to the secretome of A. castellanii

To assess whether the isolated fractions induced cellular necrosis or apoptotic death, CHO and T98G cells were double-stained with PI to probe loss of cell membrane integrity of necrotic cells and annexin V, which stains phosphatidylserine residues on the surface of early apoptotic cells. Both untreated controls of CHO (Figure 8A) and T98G (Figure 8E) cells displayed 100% and 97.9% of viable unlabeled cells (PI/ annexin V, respectively), whereas saponin treated CHO and T98G cells were 99.8% and 92.7% double-stained (PI+/ annexin V+), indicating necrosis (Figures 8B and F, respectively). EVs-treated CHO cells displayed 72.8% of necrotic cells (PI+/ annexin V+, Figure 8C). In turn, treatment with EVs-free supernatant resulted in a mixed population of 65% necrotic (PI+/ annexin V+) and 21.9% apoptotic cells (PI/ annexin V+, Figure 8D).

Figure 8.

Figure 8.

Evaluation of cell death upon treatment of CHO and T98G cells with EVs or EVs-free supernatant. Cells were stained with the Annexin V-FITC (green)/ PI (orange) kit, fluorescence images were recorded and the intensity of cell analyzed for each channel. (A-D) CHO evaluation upon treatment with A. castellanii EVs. (A) untreated CHO control, (B) saponin treated CHO, (C) EVs treated and (D) EVs-free supernatant treated CHO cells. (E-H) T98G treatment with A. castellanii EVs. (E) untreated T98G cells, (F) saponin treated T98G, (G) EVs treated and (H) EVs-free supernatant treated CHO cells. Pictures bellow each graph are representative of the microscopy images. Saponin treated CHO or T98G cells, and CHO treated with EVs or EVs-free supernatant displayed double positivity (PI+/Annexin V+), with strong stain of nuclei (orange) and phosphatidylserine on cell membrane (green), suggesting a necrotic process. T98G cells treated with EVs or EVs-free supernatant displayed a single stain (PI/Annexin V+), suggesting apoptosis.

For T98 cells, EVs treatment resulted in 60.6% apoptotic cells (Figure 8G). As observed for CHO cells, T98G cells treatment with EVs-free supernatant displayed a mixed population of 11.9% necrotic and 62.5% apoptotic cells (Figure 8H).

Discussion

The first shedding of EVs in protozoa was described in trypomastigotes derived from T. cruzi culture [61]. Subsequently, EVs secretion was described for other trypanosomatid species such as T. brucei [44,45] and Leishmania sp [42,43]., Plasmodium spp [41]., nematodes [48-50], trematodes and the amoeba species D. discoideum [52]. Hence, production of EV appears to be a common mechanism for secretion among the protozoa.

The EVs described for these protozoa are in most reports, exosomes with a diameter ranging from 30 to 100 nm, with a wide variety of functions, from playing a role in the host-parasite relationship [45,50] to inducing carcinogenic process, due to the presence of micro RNA and delivery through the EVs to the host cell environment [62]. In D. discoideum, Taticheff and collaborators [52] described the presence of three EVs populations: smaller than 50 nm nanovesicles, capable of carrying molecules from the Golgi to outside of the amoeba, between 50–150 nm and vesicles larger than 150 nm. Trophozoites of A. castellanii release bilayered spherical structures with a larger diameter and greater polydispersion than those described for other parasites, specifically when compared to the EVs described in T. cruzi, which presents vesicles ranging from 20 to 80 nm in diameter [61] or D. discoideum, with vesicles smaller than 200 nm in diameter [52]. However, as we have used differential centrifugation for the preparation of large amounts of EVs, this could result in the recovery of different EVs populations compared to other techniques [52,61,63], such as size exclusion or filtration. Additionally, its main limitation is the co-precipitation of these membranous structures with large protein aggregates, nucleosomal fragments or apoptotic bodies, which could result in lower sample purity [64,65].

EVs heterogeneity was confirmed by electron microscopy imaging and DLS; however, the DLS has detected EVs > 400 nm, which could be the result of the association of two or more EVs, detected as a single particle by this laser-beam based technique [66,67]. Such large structure may form during collection of EVs by centrifugation and pelleting. However, both methodologies displayed correlation, making our data in relation to EVs dimension even more accurate.

Little is known about the mechanism by EVs are secreted from fungi, bacteria and protozoa. In fungi, for example, the presence of molecules such as lipids, glycolytic pathway enzymes, proteases and nuclear material have already been described in several yeasts [37–45]. More specifically for the genus Acanthamoeba, there is no description of the molecular composition of EVs. However, in the present work, we describe the secretion of molecules that were also described in EVs from distinct microbial origin. GC-MS was performed for the analysis of EVs' sterols, which identified sterols such as the cholesterol derivative [(3-β)-cholest-5-en-3-yl]oxy]trimethyl]-silane, an ergosterol analog [(ergosta-5,7,22-trien-3β-yloxi)trimethyl]-silane and stigmasta (stigmasta-5,7,22-trien-3α-ol) and fatty acids with carbon chains ranging from 14 to 22 carbons. Ergosterol is a typical sterol isolated from fungal cell membranes, whereas stigmasta is commonly found in plant roots and algae [68]; both sterol have been described in total extracts of A. polyphaga [69]. The presence of stigmasta appears to be linked to metabolism control. For instance sterols from Anacardium occidentale, were intravenously administered in dogs for glycemic stabilization [68]. Another possible function of long chain fatty acids described in A. castellanii could be related to some step in membrane remodeling, as described of A. polyphaga [70].

The dearth of purification techniques for the isolation and standardized protocols for the characterization of EVs has impaired the best understanding and elucidation of the functional properties and comparison of EVs from distinct organisms. However, to validate our results, we compared the proteins obtained in EVs of A. castellanii to previously published EVs vesicles characterization of T. cruzi [71], L. major [43] and Plasmodium sp [72]. Some similar markers were found, such actin (L8HCZ7 as found in T. cruzi, L. major and Plasmodium sp.), heat shock proteins hsp83 (L8H6T6, as found in T. cruzi and L. donovani) and hsp60 (L8GUV2 as found in T. cruzi), histone 2B (L8H4F8 as found in L. major and Plasmodium sp.) and serine proteases (L8H1H6 and L8HEC6 as found in T. cruzi). However, a more elaborated comparison of protozoan EVs proteins needs to be performed.

When comparing the secretome of the distinct growth conditions, we could clearly observe a compartmentalization of proteins in each of the distinct fractions. This compartmentalization alone raises the hypothesis of a directed participation of the EVs in cell-cell communication, due to the presence of cell signaling molecules, as also hypothesized for D. discoideum [73–75]. Such hypothesis is supported by our data, which has shown that the number of proteins with biological functions related to cell signaling, ribosomal proteins and locomotion are exclusive to EVs. In turn, the EVs-free secretome, carrying carbohydrate metabolism related and depolymerases proteins, would be directed to the extracellular digestion and nutrient acquisition.

A. castellanii secreted proteins in PYG rich medium were related primarily to locomotion and signaling pathways. Specifically, A. castellanii adaptation to adverse conditions under nutritional stress (glucose alone) resulted in the secretion of molecules related to protein and amino acid metabolism, cellular stress and oxidative metabolism. The nutritional stress also became determinant in the metabolism of carbohydrates used by the amoeba, making it even more evident that the PYG medium for later trials mimics an ideal culture condition for amoebae. Besides the detection of glycosyl hydrolases and amylases in both culture conditions, the profile of detected enzymes revealed an enriched set of carbohydrate hydrolyzing enzymes in conditions of protein starvation, including a α-1,4-glucan phosphorylase and glucan (α-1,4) branching enzyme, for starch and glycolipids/glycoproteins digestion respectively, in order to increase energy acquisition/production.

The glycolysis enzyme enolase was also identified in EVs secreted by A. castellanii trophozoites in both culture media. Enolase is usually induced during cyst formation, but its role in the cyst cellulose inner layer polymerization is unclear; EVs could be strictly involved in the trafficking of this enzyme to the cell surface [76]. We did not observe cysts after 48 hours of growth in the glucose media (data not show); however these culture conditions are unstable for the growth of the trophozoite phase for longer periods. Remarkably, when A. castellanii is cultivated in glucose medium, they secreted enzymes related to pentose phosphate shunt for the glucose de novo synthesis, despite availability of this carbon source. All this plasticity in the metabolism of carbohydrates empowers amoeba to use different resources to be able to succeed during the process of colonization of distinct niches.

The importance and role of secreted proteases in the pathogenesis of infectious diseases has been established for several microorganisms [27–30,35–41,45], including different species of parasites, such as Trichomonas vaginalis [77], Giardia lamblia [78], P. falciparum [79] and Leishmania sp [42,43].. For instance, Entamoeba histolytica secretes cysteine proteases (EhCP112) that degrades the protective mucus barrier of the intestine and breaks epithelial cells monolayers. Simultaneously, it promotes intestinal invasion and extra-intestinal infection [80,81]. A. castellanii produces serine, cysteine and metalloproteases, and extracellular protease activities are increased in pathogenic Acanthamoeba strains [13,82]. T4 genotype of A. castellanii secretes mainly serine proteases, whereas other nonpathogenic amoebae are able to produce metallo and cysteine proteases [83]. This class of proteins plays a role in both pathogenicity [24,25] and amoeba differentiation between cist/trophozoite [76,83]. Proteases were remarkably abundant in the secretome of A. castellanii.

Our data also demonstrates that both fractions of the secretome of A. castellanii are able to reduce cell viability of epithelial cells (CHO) and blood-brain barrier cells (T98G). When CHO cells are incubated with EVs, they initially accumulate on the surface and their contents diffuses to the cytoplasm causing cell death by necrosis (PI+/ annexin+); EVs-free supernatant, in the other hand, induced a mixed population of major necrotic and some apoptotic cells. T98G gliobalstoma cells treatment with either EVs, also resulted in vesicle accumulation on the surface, with subsequent phagocytosis; however random accumulation of these structures can be observed in the cytoplasm without content diffusion and subsequent cell death occurs by apoptosis; EVs-free supernatant, in turn, caused death mainly by apoptosis, but a small population of necrotic cells could be also observed. As EVs displayed cytotoxicity to either CHO or T98 mammalian cell models tested, cell death mechanism was lineage dependent (necrotic and apoptotic, respectively). But commonly to both lineages, inhibition of proteases resulted in no damage to these cells, as we concluded that these enzymes constitute one of the main virulence factor directly implicated to host tissue damage.

The presence of proteases, kinases and glycosidases in EVs could contribute with the infection process in humans, since these molecules enable the parasite to establish and colonize host tissues. EVs may themselves be involved in the modulation of the interaction between A. castellanii itself and host cells, and mediate the tropism of certain strains of A. castellanii to retinal tissue (ocular keratitis) and central nervous system [5,6,11,14,20–23]. Huang and collaborators showed that proteins secreted by A. castellanii, induced the detachment of mammalian cells and assigned this effect to the M20/M25/M40 aminopeptidase superfamily proteins. These detached cells floated and were then ingested and killed by amoeba cells [84]. These proteins were not found in the EVs or EVs-free supernatant, but other molecules present in the secretome of A. castellanii could induce similar functions. The secretome of A. castellanii may also participate in immunomodulation, being able to induce response patterns cytokines and recruitment of cells, suggesting also that there may be a difference between the secretomes of the different genotypes.

The hypothesis that A. castellanii serves as a host that selects for virulence trait by preying upon parasitizing microorganism is attractive, but still remains to be elucidated [85]. Recently, the interaction of A. castellanii and C. neoformans was demonstrated to have an impact on virulence, as a more virulent phenotype of C. neoformans expressing distinct available surface polysaccharides, such as chitin and distinct virulence traits, could be isolated upon interaction with A. castellanii [86]. We hypothesize that one mechanism for imposing selection pressures on fungi might be through the digestion of cell wall surface sugars, since glucosidases, xylosidases and mannosidases are present in the A. castellanii secretome, facilitating the fungal phagocytosis by the amoeba and modulating positively their adaptation to its intracellular milieu, with subsequent production of amoeba resistant strains, potentially more pathogenic.

In summary, we provide the first description and characterization of EVs from A. castellanii. Our results shed new light for the development of new pharmacological options that interfered with EVs secretion, as reducing the damage provoked by A. castellanii to tissues, they could be useful therapeutic agents for amebiasis.

Materials and methods

Culture of Acanthamoeba castellanii

A. castellanii (ATTC 30234) were obtained from the American Type Culture Collection (ATCC, Manassas, VA). Trophozoites were cultured as adherent cells under axenic condition until reached confluence in peptone-yeast extract-glucose (ATCC 712 medium PYG; 20.0 g/L proteose peptone, 1.0 g/L yeast extract, supplemented with 0.4 mM CaCl2, 4 mM MgSO4, 2.5 mM Na2HPO4, 2.5 mM KH2PO4, 3.4 mM sodium citrate, 0.05 mM Fe(NH4)2(SO4)2, pH 6.5, 100 mM glucose, filter-sterilized). The tissue culture flasks were kept at 28°C in the absence of light. A castellanii was subcultured every 48h and, under these conditions, >99% of amoeba were trophozoites. For A. castellanii cultivation under nutritional stress, trophozoites were kept under the same conditions as described above, in a similar medium without addition of peptone and yeast extract, denominated glucose medium.

Culture of animal cells

Chinese hamster ovary (CHO) cells were obtained from the Cell Bank of Rio de Janeiro and cultivated in HAM F-12 medium supplemented with 1.2 g/L NaHCO3, 5% fetal calf serum (Cultilab), 2% non-essential amino acids and 1% penicillin/streptomycin (LifeTechnologies). T98G cells were cultivated in high glucose DMEM medium supplemented with 5% FCS, 1% non-essential amino acids and 1% penicillin/streptomycin. Cells were maintained at 37oC and 5% CO2 and passaged every two days until use.

Scanning electron microscopy

A. castellanii (1 × 106 cells) was cultured in PYG on the surface of a 13 mm diameter glass cover slip for 3 h at RT. After, cells were washed with 1 M sodium cacodylate buffer, followed by a fixation step using 1 M sodium cacodylate buffer and 2.5% glutaraldehyde for 2 h at RT. Fixed cells were treated with a 1% osmium tetroxide for 30 min, then dehydrated in serially increasing acetone concentrations (30%, 50%, 70%, 90% and 100%). We performed the critical point drying followed by metallization with gold, where the sample received a thin layer of approximately 52 nm coating. Samples were then analyzed in a JEOL JMS-6490LV microscope [87].

Secretome preparation

After 48 h of cultivation in both PYG and glucose medium, A. castellanii culture supernatants were collected and centrifuged at 1,100 × g for 10 min. The cell pellet was discarded and remaining trophozoites and cell debris were removed by an additional step of supernatant filtration using a 0.8 μm membrane filter (Merck Millipore). The filtered material was collected in sterile glass flasks and conditioned at 4–8°C until further processing for extracellular vesicles (EVs) isolation. One liter of cell-free supernatants was concentrated approximately 20-fold using a 10 KDa cut-off membrane in an Amicon ultrafiltration system (Merck Millipore) and then ultracentrifuged at 100,000 × g for 1 h at 4°C. Supernatants were collected and saved as soluble fractions (or EVs-free supernatant). Pellets containing EVs were further washed twice with a 0.22 μm filtered phosphate-buffered saline (PBS, 140 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, 17 mM Na2HPO4, pH 7.2)(Merck Millipore), and ultracentrifuged at 100,000 × g for 1 h at 4°C. The protein concentrations of EVs and EVs-free supernatant fractions from both growth conditions were determined by the bicinchoninic acid (BCA) method according to manufacturer´s instructions (Life Technologies).

Dynamic light scattering (DLS)

EVs were diluted in filtered PBS and their size distribution was determined by Quasi-Elastic Light Scattering in a 90Plus/BI-MAS Multi Angle Particle Sizing analyzer (Brookhaven Instruments, Holtsville, NY), set for detection of populations ranging from 10–1500 nm. Multimodal size distribution analysis of particles was calculated from the values of intensity weighted sizes obtained from the non-negatively constrained least squared (NNLS) algorithm [37]. Measurements of two biological replicates were performed at 25°C, in duplicates.

Transmission electron microscopy

EVs from A. castellanii were negatively stained to determine their dimensions as described elsewhere [88]. For this procedure, 10 µL of EVs suspension were deposited on copper grids (200 mesh) and air-dried. Grids were treated with Formvar 0.3% and charred. EVs were negatively contrasted with 1% (m/v) uranyl acetate. The micrographs were taken in an electronic microscope JEOL 1200EX of 80 kV and images analyzed by Image J (NIH, Bethesda) in order to determine the vesicles diameter. At least 200 vesicles were analyzed in the 3 grids prepared for each of 2 biological replicates from each growth condition.

Lipids analysis

Lipid composition of EVs was resolved by high performance thin layer chromatography (HPTLC). Initially, 100 µg of EVs from two biological replicates were partitioned in chloroform: methanol: water (2:1) [57,89]. Then the lower phase was applied to a TLC silica gel plate (Merck). For neutral lipid analysis, the lipid extract was resolved in a hexane: ether: acetic acid (80:40:2 v/v/v) and plates developed with a solution containing 0.5 mg/mL of FeCl3 in 5% (v/v) acetic acid and 5% (v/v) sulfuric acid. Plates were heated at 100ºC for 3–5 min and lipid bands were compared to commercial standards of triglyceride, diacylglyceride, monoacylgrlyceride, free fatty acid, sterol and esterified cholesterol (Sigma-Aldrich).

Sterol and free fatty acids (FFA) were also characterized by chromatography associated with mass spectrometry (GC-MS) in the facility at the Federal University of Rio the Janeiro, using a total of 20 µg of lipids extract from two independent replicates of isolated EVs. Extraction of lipids was carried out in duplicate using a mixture containing chloroform: methanol: water (0,5:1:0,4 v/v/v). Suspensions were vortexed until the appearance of two or more phases; methanol was added until the solution became homogeneous. Samples were vortexed every 5 min for 1 h and then centrifuged at 1,100 ×g for 20 min. The supernatant was collected and reserved. The pellet formed was subject to the same procedure described above and the supernatant was pooled with the previous one. Finally, 1 mL of chloroform: water (1:1) was added, fractionating the material in 2 phases, which was then vortexed and centrifuged at 1,100 ×g for another 30 min. At the end of the extraction, the organic phase extracted from our samples was collected [90].

For the saponification and derivatization, the samples were dried in N2 [91], suspended in 1 mL of 25% alcoholic potassium (25 g KOH in 35 mL H2O, supplemented with ethanol for 100 mL) for 1 min and directly subjected to 85°C heating for 1 h in a water bath. Upon cooling the samples at RT, a mixture of 1 mL of distilled H2O and 2 mL of heptane was added. The sample was vortexed, centrifuged at 1,100 ×g for 20 min and dried in a chemical hood with N2. For signaling, 50 µL of BSTFA: TMCS (99: 1) and 50 µL of pyridine were added to each sample and heated at 65°C for 1h. Finally, 1 µL was injected into a Shimadzu GC-MS model GP2010 Plus GC-MS, coupled to an HP Ultra 2 (5% Phenyl-methylpolysiloxane), Agilent (25 mx 0.20 mm X 0.33 µm). The injector was maintained at 250°C, splitless mode. The temperature of the column was raised to 50–270°C with a heating rate of 18°C/ min, and 270–300°C with a heating rate of 1°C/ min and then maintained for 6 min. Helium was used as drag gas with linear velocity of 33.0 cm/sec. A detector containing an electron ionization source (EI-70 eV) and a quadrupole mass analyzer, operated in sweeps of 40 to 600 u.m.a. was used for the detection by mass spectrometry. The interface and the ion source were maintained at 280°C. Identification of the constituents of the mixture was made by comparing their mass spectra with those of the NIST05 library [92].

Liquid chromatography- tandem mass spectrometry (LC-MS/MS)

Preparation of protein samples for mass spectrometry analysis was carried out according to previously described protocols [93]. For mass spectrometry, we produced three biological replicates of either EVs or EVs-free supernatant from each growth condition (PYG or glucose) and the analysis of each sample was performed in duplicates. Initially, 100 μg of each sample was dried in a speed vac (Eppendorf), dissolved in 18 µL of 7 M Urea/ 2 M thiourea, and added of 2 µL 1 M HEPES. Samples were reduced by adding 2.2 µL of 100 mM 1,4-dithiothreitol and incubated at 30ºC for 1h. After, 2.5 µL of 400 mM iodoacetamide was added and samples incubated for 30 min in the dark at RT. A volume of 175 µL of MS compatible water (Tedia Corporation) was added to dilute the urea /thiourea, and trypsin (Promega) diluted in acetic acid was added to a final concentration of 0.1 µg/μL. Samples were incubated overnight at 37ºC. Then, 2 µL of 10% TFA was added to a final concentration of 0.1%, and the samples cleaned up with an Ultra micro Spin Column (Harvard Apparatus). After drying the samples in speedvac, tryptic peptides were re-dissolved in 10 µL of 0.1% trifluoroacetic acid (TFA) and the mixture (4 µL) was loaded onto an in-house packed 15 cm x 75 μm column filled with 3 μm ReproSil C18 resin (Dr. Maisch GmbH) using the NanoLC-Ultra nanoliquid chromatography system (Eksigent Technologies). Peptides were first loaded onto a trap column (20 × 0.2 mm) packed with Reprosil-Pur 120 C18-AQ 5 µm particles (Dr. Maish, Germany). After 4 min washing with solvent A [H2O: acetonitrile (95:5, v/v), 0.1% (v/v) formic acid (FA)] peptides were eluted during the gradient on a 150 × 0.075 mm column packed with C18 Reprosil Gold 300 3 µm particles (Dr. Maish) at a flow rate of 300 nL.min−1. Gradient was 5–35% of solvent B [H2O: acetonitrile (5:95, v/v), 0.1% (v/v) FA] for 110 min, 35–95% B for 20 min and 90% B for 10 min; equilibration was carried out for 20 min at 5% B. For sample analysis in the LTQ-Orbitrap (ThermoFisher), the mass spectrometry DDA cycle consisted of a survey scan acquired in one μscan within the range of m/z 300–1800 at target mass resolution of 60,000 FWHM (full width at half-maximum) and target value of 1E06 ions. Survey scan was followed by MS/MS fragmentation of the ten most abundant multiply charged precursors. Spectra were acquired in one μscan under the normalized collision energy of 35% and target value of 1E04 ions in the linear ion trap (ion selection threshold 400 counts; precursor ions isolation width 4 a.m.u.). Activation parameter q = 0.25 and activation time of 30 ms were applied. Previously fragmented precursors were dynamically excluded for 90 s. Data were acquired using the Xcalibur software (version 2.0, Thermo) LC-MS/MS runs were saved as .raw files.

Mass spectrometry data analysis

MS/MS spectra in .raw format were processed in PattrernLab for Proteomics software v.4.0 (PMID: 2658470-Computacional Proteomics- Fiocruz) Peptide sequence matching (PSM) was performed using the Comet algorithm (PMID: 23148064). The coding sequences present in the genome of A. castellanii were downloaded from Uniprot (www.uniprot.org) and used as database. The search was performed considering the following parameters: (1) two trypsin missed cleavages allowed, (2) precursor peptide mass tolerance of 10 ppm, (3) MS/MS fragment mass tolerance of 0.6 Da, (4) cysteine carbamidomethylation as fixed modification and (5) methionine oxidation as variable modification. For protein identification we considered using a false discovery rate (FDR) set to 1%.

Identified proteins in PYG and glucose EVs and EVs-free supernatant

The list of identified proteins in the three biological replicates of each specific condition (PYG-EVs, PYG-EVs-free supernatant, glucose-EVs or glucose-EVs-free supernatant) were used to construct Venn diagrams (BioinfoGP, CNB-CSIC), and the commonly identified proteins in the three biological replicates of each condition were recorded. Proteins were grouped according to their biological function, after automatically annotated using the software Blast2go (BioBam, Spain) and manually checked on the UniProt Protein Database (http://www.uniprot.org/). Groups consisted of proteins related to cytoskeleton, structural membrane component, locomotion, carbohydrate metabolism, protein and amino acid metabolism, lipid metabolism, nucleotide metabolism, energetic metabolism, oxidative metabolism, cellular stress, mitochondrial proteins, nucleus, proteases, ribosomal, signaling, miscellaneous and unidentified proteins (undefined functions). Identified proteins exclusively present in EVs, in both EVs and EVs-free supernatant or exclusively present in the EVs-free supernatant were organized depending growth condition, and are presented as Supplementary Tables 1 and 2.

SDS-PAGE electrophoresis and zymography

Peptidases have been characterized by MS and confirmed as described previously [94]. In summary, 0.1% gelatin as substrate was incorporated into a polyacrylamide gel containing sodium dodecyl sulfate (SDS-PAGE). The equivalent to 50 μg of proteins from EVs or EVs-free supernatants from each growth condition were applied into each gel slot and samples submitted to electrophoresis at a constant current of 100 V at 4°C, until the bottom edge of the gel was reached. Gels were incubated in 2.5% Triton X-100 for 1 h at room temperature under constant agitation. The same gel set-ups were then further incubated in the following buffer conditions for 48 h at 37°C in order to determine the best pH value for peptidase activity: sodium acetate buffer 0.1 M (pH 3.0 and 5.0), PBS buffer (pH 7.0) and glycine buffer 0.1 M (pH 9.0). Gels were stained overnight with 0.2% solution of Coomassie Brilliant Blue R-250 in methanol/ acetic acid/ water (50:10:40) and destained in methanol: acetic acid: water (5:10:85). Gels were dried and had their images scanned for further digital processing.

Confocal microscopy of CHO and T98G cell lines.

CHO and T98G and cells were plated at 105 cells/well onto 24-well plates covered with sterile glass coverslips, and cultured overnight at 37ºC/5% CO2. EVs (20 µg) were stained with 3 mM Dil (1,1'-Dioctadecyl-3,3,3', 3'-Tetramethylindocarbocyanine Perchlorate; DiIC18, Life Technologies) at 40C for 30 min. EVs were ultra-centrifuged at 100,000 xg for 1 h and the were re-suspended in 3 mL of 0.22 µm filtered PBS, and washing repeated three more times. EVs were added to both CHO and T98G cells and incubated for different intervals (5, 10, 15, 30, 45 and 60 min). After the incubations, wells were washed will PBS and fixed with 4% paraformaldehyde for 40 min at 370C. Cells were washed and blocked with 1% PBS-BSA. Cells were washed and labelled with Cholera Toxin Subunit B (CtxB, Recombinant)- Alexa Fluor 488 (Sigma-Aldrich) at 1 µg/ml for 1 h at 40C. After three more washes, cells were labeled with 4,6-diamidino-2-phenylindole (DAPI) (10 µgml−1) for 30 min at room temperature. The coverslips were washed three times with PBS and mounted in 50% glycerol and 50mM n-propyl gallate in PBS. The slides were visualized in a Confocal Microscope Zeiss LSM 710NLO-Meta with 40x objective DAPI-labelled cell nuclei was excited with a two-photon excitation regime using a Mai Tai HPpulsed infrared laser (Spectra-Physics, Lasers) at 740 nm. CtxB-Alexa 488 and DilC18-labelled EVs were excited with argon ion laser at 488 nm and a diode laser at 561 nm, respectively. Emissions were collected in thee separated channels using bandpass filters for green (BP 500–550 IR), red (BP 575–615 IR) and blue (BP 435–485 IR) channels. All images were collected using the AxioVision 4.8. software (Carl Zeiss). Pinhole diameters were set to 1 Airy unit corresponding to a z resolution of 0.8 μm. Displayed results are representative of three independent experiments.

MTT cell culture viability

CHO (hamster ovarium) and T98G cells were plated on a 96-wels plate (2 × 105 cells/well) and cultured overnight at 37ºC/5% CO2. Wells were washed with medium in the absence of serum. Serial dilutions (from 20 to 0.010 µg/mL) of either EVs or EVs-free supernatants in serum-supplemented medium were added to cells. As controls, CHO or T98 were also incubated with irrelevant vesicle extracted from J774.16 macrophage-like cells, PYG medium or BSA at distinct proteins concentrations. Additionally, EVs and EVs-free supernatant were added in the presence of protease inhibitors phenylmethylsulfonyl fluoride (PMSF), phenantroline, pepstatin A, trans-Epoxysuccinyl-L-leucylamido(4-guanidino)butane (E-64) and the complete mini protease inhibitors cocktail (Sigma-Aldrich) following the manufacture's recomended concentrations. Plates were incubated overnight at 37ºC/5% CO2, washed with PBS, and then cell viability was assessed by the Methylthiazolyldiphenyl- tetrazolium bromide (MTT) assay [95]. Experiments were performed in duplicates with the three biological replicates of each EVs or EV-free supernatant from the distinct growth condition.

Annexin/PI apoptosis assay

Using an 8-well culture chamber (Lab-Tek®), CHO or T98G were plated at 5 × 105 cells/well and cultured overnight at 37ºC/5% CO2. Wells were washed with medium in the absence of serum and 20 µg/mL of either EVs or EVs-free supernatant were added to the cells for 6 hours. Saponin has been used as positive control for cell death [96], and for this approach, both cell lines were treated with 100 mM of saponin for 15 min at 4°C [97]. After this period, cells were fixed with 4% paraformaldehyde for 30 min at RT, and then washed with sterile PBS. For the apoptosis assay, 10 µL of the ligand buffer and 90 µL of sterile PBS were added to 8 µL of the propidium iodide (PI) solution and 8 µL Annexin V-FITC conjugated (Annexin V-FITC Apoptosis Detection Kit – SIGMA) and chambers incubated for 15 min at RT in the absence of light. This combination allows the differentitation of viable cells (PI, annexin V), apoptotic cells (PI, annexin V+) and necrotic cells (PI+, annexin V+). The slides were then prepared for visualization in the Zeiss Axiovert 200 fluorescence inverted phase and contrast microscopy using a 100X objective (Carl Zeiss MicroImaging, Inc.). Annexin V-FITC and PI labeled cells were detected by the GFP and TRITC filters, respectively and fluorescences collected separated in two channels. DIC and fluorescence microscopy pictures were recorded. Images were analyzed by the Axiovision (LE) according to manufacturer's instructions and Image J (NIH, Bethesda) as described [98,99]. Cells in each picture were individually gated and fluorescence intensitiy of each individual cells were recorded by channel. At least 500 cells were analyzed for each condition. Fluorescence intensity for Annexin V-FITC and PI were plotted for each cell. Displayed results are representative of three independent experiments.

Statistical analysis

Unpaired Student T-test or Spearman correlations were performed using Prism version 7.00 for Windows, GraphPad Software (La Jolla California USA, www.graphpad.com).

Supplementary Material

1451184.zip

Funding Statement

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (Programa Pesquisa para o SUS) Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (Apoio às Instituições de Ensino e Pesquisa Sediadas no Estado do Rio de Janeiro) Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (Apoio a Projetos Temáticos no Estado do Rio de Janeiro) National Institutes of Health (5R01HL059842) National Institutes of Health (5R37AI033142) National Institutes of Health (5R01AI033774) National Institutes of Health (5R01AI052733).

Disclosure of potential conflicts of interest

No potential conflicts of interest were disclosed.

Acknowledgments

The data in this paper are from a thesis to be submitted by Diego de Souza Gonçalves in partial fulfillment of the requirements for the degree of Doctor of Philosophy at the Microbiology and Parasitology Department, Fluminense Federal University, Brazil.

References

  • [1].Magnet A, et al.. Molecular characterization of Acanthamoeba isolated in water treatment plants and comparison with clinical isolates. Parasitol Res. 2012;111:383–392. [DOI] [PubMed] [Google Scholar]
  • [2].Gianinazzi C, et al.. Screening Swiss water bodies for potentially pathogenic free-living amoebae. Res Microbiol. 2009;160:367–374. [DOI] [PubMed] [Google Scholar]
  • [3].Tan SK, et al.. Fatal acanthamoeba encephalitis in a patient with a total artificial heart (syncardia) device. Open Forum Infect Dis. 2014;1:ofu057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4].Rodriguez-Zaragoza S. Ecology of free-living amoebae. Crit Rev Microbiol. 1994;20:225–241. [DOI] [PubMed] [Google Scholar]
  • [5].Booton GC, et al.. Molecular and physiological evaluation of subtropical environmental isolates of Acanthamoeba spp., causal agent of Acanthamoeba keratitis. J Eukaryot Microbiol. 2004;51:192–200. [DOI] [PubMed] [Google Scholar]
  • [6].Khan NA. Acanthamoeba: biology and increasing importance in human health. FEMS Microbiol Rev. 2006;30:564–595. [DOI] [PubMed] [Google Scholar]
  • [7].Huang FC, et al.. Characterizing clinical isolates of Acanthamoeba castellanii with high resistance to polyhexamethylene biguanide in Taiwan. J Microbiol Immunol Infect. 2015. [DOI] [PubMed] [Google Scholar]
  • [8].Huang SW, et al.. Isolation and identification of Legionella and their host amoebae from weak alkaline carbonate spring water using a culture method combined with PCR. Parasitol Res. 2011;109:1233–1241. [DOI] [PubMed] [Google Scholar]
  • [9].Marciano-Cabral F, Han K, Powell E, et al.. Interaction of an Acanthamoeba human isolate harboring bacteria with murine peritoneal macrophages. J Eukaryot Microbiol. 2003;50 Suppl:516–519. [DOI] [PubMed] [Google Scholar]
  • [10].Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev. 2003;16:273–307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [11].Martinez AJ, Visvesvara GS. Free-living, amphizoic and opportunistic amebas. Brain Pathol. 1997;7:583–598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [12].Siddiqui R, Aqeel Y, Khan NA. The development of drugs against Acanthamoeba infections. Antimicrob Agents Chemother. 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].Lorenzo-Morales J, Khan NA, Walochnik J. An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment. Parasite. 2015;22:10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [14].Lorenzo-Morales J, et al.. Acanthamoeba keratitis: an emerging disease gathering importance worldwide? Trends Parasitol. 2013;29:181–187. [DOI] [PubMed] [Google Scholar]
  • [15].Wynter-Allison Z, et al.. Acanthamoeba infection as a cause of severe keratitis in a soft contact lens wearer in Jamaica. Am J Trop Med Hyg. 2005;73:92–94. [PubMed] [Google Scholar]
  • [16].Alsam S, Sissons J, Jayasekera S, et al.. Extracellular proteases of Acanthamoeba castellanii (encephalitis isolate belonging to T1 genotype) contribute to increased permeability in an in vitro model of the human blood-brain barrier. J Infect. 2005;51:150–156. [DOI] [PubMed] [Google Scholar]
  • [17].Sant'ana VP, et al.. Cytotoxic activity and degradation patterns of structural proteins by corneal isolates of Acanthamoeba spp. Graefes Arch Clin Exp Ophthalmol. 2015;253:65–75. [DOI] [PubMed] [Google Scholar]
  • [18].Hadas E, Mazur T. Biochemical markers of pathogenicity and virulence of Acanthamoeba sp. strains. Parasitol Res. 1993;79:696–698. [DOI] [PubMed] [Google Scholar]
  • [19].Choi DH, Na BK, Seo MS, et al.. Purification and characterization of iron superoxide dismutase and copper-zinc superoxide dismutase from Acanthamoeba castellanii. J Parasitol. 2000;86:899–907. [DOI] [PubMed] [Google Scholar]
  • [20].Kim WT, et al.. Comparison of specific activity and cytopathic effects of purified 33 kDa serine proteinase from Acanthamoeba strains with different degree of virulence. Korean J Parasitol. 2006;44:321–330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [21].Ramirez-Rico G, Martinez-Castillo M, de la Garza M, et al.. Acanthamoeba castellanii Proteases are Capable of Degrading Iron-Binding Proteins as a Possible Mechanism of Pathogenicity. J Eukaryot Microbiol. 2015;62:614–622. [DOI] [PubMed] [Google Scholar]
  • [22].Ferrante A, Bates EJ. Elastase in the pathogenic free-living amoebae Naegleria and Acanthamoeba spp. Infect Immun. 1988;56:3320–3321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [23].Hadas E, Mazur T. Proteolytic enzymes of pathogenic and non-pathogenic strains of Acanthamoeba spp. Trop Med Parasitol. 1993;44:197–200. [PubMed] [Google Scholar]
  • [24].Khan NA, Jarroll EL, Panjwani N, et al.. Proteases as markers for differentiation of pathogenic and nonpathogenic species of Acanthamoeba. J Clin Microbiol. 2000;38:2858–2861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [25].Mitra MM, Alizadeh H, Gerard RD, et al.. Characterization of a plasminogen activator produced by Acanthamoeba castellanii. Mol Biochem Parasitol. 1995;73:157–164. [DOI] [PubMed] [Google Scholar]
  • [26].Serrano-Luna Jde J, et al.. Protease activities of Acanthamoeba polyphaga and Acanthamoeba castellanii. Can J Microbiol. 2006;52:16–23. [DOI] [PubMed] [Google Scholar]
  • [27].Joffe LS, Nimrichter L, Rodrigues ML, et al.. Potential Roles of Fungal Extracellular Vesicles during Infection. mSphere. 2016;1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [28].Kalluri R. The biology and function of exosomes in cancer. J Clin Invest. 2016;126:1208–1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [29].Schorey JS, Harding CV. Extracellular vesicles and infectious diseases: new complexity to an old story. J Clin Invest. 2016;126:1181–1189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [30].Turpin D, et al.. Role of extracellular vesicles in autoimmune diseases. Autoimmun Rev. 2016;15:174–183. [DOI] [PubMed] [Google Scholar]
  • [31].Oliveira DL, et al.. Extracellular vesicles from Cryptococcus neoformans modulate macrophage functions. Infect Immun. 2010;78:1601–1609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [32].Rodrigues ML, Godinho RM, Zamith-Miranda D, et al.. Traveling into Outer Space: Unanswered Questions about Fungal Extracellular Vesicles. PLoS Pathog. 2015;11:e1005240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [33].Oliveira DL, et al.. Biogenesis of extracellular vesicles in yeast: Many questions with few answers. Commun Integr Biol. 2010;3:533–535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [34].Oliveira DL, et al.. Characterization of yeast extracellular vesicles: evidence for the participation of different pathways of cellular traffic in vesicle biogenesis. PLoS One. 2010;5:e11113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [35].Evans-Osses I, Reichembach LH, Ramirez MI. Exosomes or microvesicles? Two kinds of extracellular vesicles with different routes to modify protozoan-host cell interaction. Parasitol Res. 2015;114:3567–3575. [DOI] [PubMed] [Google Scholar]
  • [36].Rodrigues ML, et al.. Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryot Cell. 2008;7:58–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [37].Vargas G, et al.. Compositional and immunobiological analyses of extracellular vesicles released by Candida albicans. Cell Microbiol. 2015;17:389–407. [DOI] [PubMed] [Google Scholar]
  • [38].Rodrigues ML, et al.. Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot Cell. 2007;6:48–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [39].Albuquerque PC, et al.. Vesicular transport in Histoplasma capsulatum: an effective mechanism for trans-cell wall transfer of proteins and lipids in ascomycetes. Cell Microbiol. 2008;10:1695–1710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [40].Mugnier MR, Papavasiliou FN, Schulz D. Vesicles as Vehicles for Virulence. Trends Parasitol. 2016;32:435–436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [41].Marti M, Johnson PJ. Emerging roles for extracellular vesicles in parasitic infections. Curr Opin Microbiol. 2016;32:66–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [42].Silverman JM, et al.. An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages. J Cell Sci. 2010;123:842–852. [DOI] [PubMed] [Google Scholar]
  • [43].Silverman JM, et al.. Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells. J Immunol. 2010;185:5011–5022. [DOI] [PubMed] [Google Scholar]
  • [44].Geiger A, et al.. Exocytosis and protein secretion in Trypanosoma. BMC Microbiol. 2010;10:20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [45].Szempruch AJ, et al.. Extracellular Vesicles from Trypanosoma brucei Mediate Virulence Factor Transfer and Cause Host Anemia. Cell. 2016;164:246–257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [46].Cordero EM, et al.. Proteomic analysis of detergent-solubilized membrane proteins from insect-developmental forms of Trypanosoma cruzi. J Proteome Res. 2009;8:3642–3652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [47].Sant'Anna C, et al.. Subcellular proteomics of Trypanosoma cruzi reservosomes. Proteomics. 2009;9:1782–1794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [48].Marcilla A, et al.. Extracellular vesicles from parasitic helminths contain specific excretory/secretory proteins and are internalized in intestinal host cells. PLoS One. 2012;7:e45974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [49].Buck AH, et al.. Exosomes secreted by nematode parasites transfer small RNAs to mammalian cells and modulate innate immunity. Nat Commun. 2014;5:5488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [50].Tzelos T, et al.. A preliminary proteomic characterisation of extracellular vesicles released by the ovine parasitic nematode, Teladorsagia circumcincta. Vet Parasitol. 2016;221:84–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [51].Bernal D, et al.. Surface analysis of Dicrocoelium dendriticum. The molecular characterization of exosomes reveals the presence of miRNAs. J Proteomics. 2014;105:232–241. [DOI] [PubMed] [Google Scholar]
  • [52].Tatischeff I, et al.. Dictyostelium extracellular vesicles containing hoechst 33342 transfer the dye into the nuclei of living cells: a fluorescence study. J Fluoresc. 2008;18:319–328. [DOI] [PubMed] [Google Scholar]
  • [53].Nosanchuk JD, Nimrichter L, Casadevall A, et al.. A role for vesicular transport of macromolecules across cell walls in fungal pathogenesis. Commun Integr Biol. 2008;1:37–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [54].Casadevall A, Nosanchuk JD, Williamson P, et al.. Vesicular transport across the fungal cell wall. Trends Microbiol. 2009;17:158–162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [55].Rodrigues ML, et al.. Vesicular transport systems in fungi. Future Microbiol. 2011;6:1371–1381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [56].Simons M, Raposo G. Exosomes–vesicular carriers for intercellular communication. Curr Opin Cell Biol. 2009;21:575–581. [DOI] [PubMed] [Google Scholar]
  • [57].Record M, Carayon K, Poirot M, et al.. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim Biophys Acta. 2014;1841:108–120. [DOI] [PubMed] [Google Scholar]
  • [58].Rao MB, Tanksale AM, Ghatge MS, et al.. Molecular and biotechnological aspects of microbial proteases. Microbiol Mol Biol Rev. 1998;62:597–635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [59].Diao J, et al.. A single vesicle-vesicle fusion assay for in vitro studies of SNAREs and accessory proteins. Nat Protoc. 2012;7:921–934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [60].Nicola AM, Frases S, Casadevall A. Lipophilic dye staining of Cryptococcus neoformans extracellular vesicles and capsule. Eukaryot Cell. 2009;8:1373–1380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [61].Goncalves MF, et al.. Trypanosoma cruzi: shedding of surface antigens as membrane vesicles. Exp Parasitol. 1991;72:43–53. [DOI] [PubMed] [Google Scholar]
  • [62].Chaiyadet S, et al.. Excretory/secretory products of the carcinogenic liver fluke are endocytosed by human cholangiocytes and drive cell proliferation and IL6 production. Int J Parasitol. 2015;45:773–781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [63].Lane RE, Korbie D, Trau M, et al.. Purification Protocols for Extracellular Vesicles. Methods Mol Biol. 2017;1660:111–130. [DOI] [PubMed] [Google Scholar]
  • [64].Mateescu B, et al.. Obstacles and opportunities in the functional analysis of extracellular vesicle RNA – an ISEV position paper. J Extracell Vesicles. 2017;6:1286095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [65].Momen-Heravi F, et al.. Current methods for the isolation of extracellular vesicles. Biol Chem. 2013;394:1253–1262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [66].Stetefeld J, McKenna SA, Patel TR. Dynamic light scattering: a practical guide and applications in biomedical sciences. Biophys Rev. 2016;8:409–427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [67].Frases S, Viana NB, Casadevall A. Biophysical methods for the study of microbial surfaces. Front Microbiol. 2011;2:207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [68].Alexander-Lindo RL, Morrison EY, Nair MG. Hypoglycaemic effect of stigmast-4-en-3-one and its corresponding alcohol from the bark of Anacardium occidentale (cashew). Phytother Res. 2004;18:403–407. [DOI] [PubMed] [Google Scholar]
  • [69].Raederstorff D, Rohmer M. Sterol biosynthesis de nova via cycloartenol by the soil amoeba Acanthamoeba polyphaga. Biochem J. 1985;231:609–615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [70].Jones AL, Hann AC, Harwood JL, et al.. Temperature-induced membrane-lipid adaptation in Acanthamoeba castellanii. Biochem J. 1993;290(Pt 1):273–278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [71].Bayer-Santos E, et al.. Proteomic analysis of Trypanosoma cruzi secretome: characterization of two populations of extracellular vesicles and soluble proteins. J Proteome Res. 2013;12:883–897. [DOI] [PubMed] [Google Scholar]
  • [72].Mantel PY, et al.. Malaria-infected erythrocyte-derived microvesicles mediate cellular communication within the parasite population and with the host immune system. Cell Host Microbe. 2013;13:521–534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [73].Tatischeff I. Assets of the non-pathogenic microorganism Dictyostelium discoideum as a model for the study of eukaryotic extracellular vesicles. F1000Res. 2013;2:73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [74].Loomis WF. Cell signaling during development of Dictyostelium. Dev Biol. 2014;391:1–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [75].Du Q, Kawabe Y, Schilde C, et al.. The Evolution of Aggregative Multicellularity and Cell-Cell Communication in the Dictyostelia. J Mol Biol. 2015;427:3722–3733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [76].Bouyer S, Rodier MH, Guillot A, et al.. Acanthamoeba castellanii: proteins involved in actin dynamics, glycolysis, and proteolysis are regulated during encystation. Exp Parasitol. 2009;123:90–94. [DOI] [PubMed] [Google Scholar]
  • [77].Kucknoor AS, Mundodi V, Alderete JF. The proteins secreted by Trichomonas vaginalis and vaginal epithelial cell response to secreted and episomally expressed AP65. Cell Microbiol. 2007;9:2586–2597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [78].Ringqvist E, et al.. Release of metabolic enzymes by Giardia in response to interaction with intestinal epithelial cells. Mol Biochem Parasitol. 2008;159:85–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [79].Vincensini L, et al.. Proteomic analysis identifies novel proteins of the Maurer's clefts, a secretory compartment delivering Plasmodium falciparum proteins to the surface of its host cell. Mol Cell Proteomics. 2005;4:582–593. [DOI] [PubMed] [Google Scholar]
  • [80].Lidell ME, Moncada DM, Chadee K, et al.. Entamoeba histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective colonic mucus gel. Proc Natl Acad Sci U S A. 2006;103:9298–9303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [81].Ocadiz R, et al.. EhCP112 is an Entamoeba histolytica secreted cysteine protease that may be involved in the parasite-virulence. Cell Microbiol. 2005;7:221–232. [DOI] [PubMed] [Google Scholar]
  • [82].Mattana A, et al.. ADP and other metabolites released from Acanthamoeba castellanii lead to human monocytic cell death through apoptosis and stimulate the secretion of proinflammatory cytokines. Infect Immun. 2002;70:4424–4432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [83].Dudley R, Alsam S, Khan NA. The role of proteases in the differentiation of Acanthamoeba castellanii. FEMS Microbiol Lett. 2008;286:9–15. [DOI] [PubMed] [Google Scholar]
  • [84].Huang JM, et al.. Pathogenic Acanthamoeba castellanii Secretes the Extracellular Aminopeptidase M20/M25/M40 Family Protein to Target Cells for Phagocytosis by Disruption. Molecules. 2017;22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [85].Guimaraes AJ, Gomes KX, Cortines JR, et al.. Acanthamoeba spp. as a universal host for pathogenic microorganisms: One bridge from environment to host virulence. Microbiol Res. 2016;193:30–38. [DOI] [PubMed] [Google Scholar]
  • [86].Rizzo J, et al.. Analysis of multiple components involved in the interaction between Cryptococcus neoformans and Acanthamoeba castellanii. Fungal Biol. 2017;121:602–614. [DOI] [PubMed] [Google Scholar]
  • [87].Sangenito LS, et al.. HIV aspartic peptidase inhibitors are effective drugs against the trypomastigote form of the human pathogen Trypanosoma cruzi. Int J Antimicrob Agents. 2016;48:440–444. [DOI] [PubMed] [Google Scholar]
  • [88].Park AJ, Surette MD, Khursigara CM. Antimicrobial targets localize to the extracellular vesicle-associated proteome of Pseudomonas aeruginosa grown in a biofilm. Front Microbiol. 2014;5:464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [89].Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497–509. [PubMed] [Google Scholar]
  • [90].Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911–917. [DOI] [PubMed] [Google Scholar]
  • [91].Arthington-Skaggs BA, Jradi H, Desai T, et al.. Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans. J Clin Microbiol. 1999;37:3332–3337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [92].Skogerson K, Wohlgemuth G, Barupal DK, et al.. The volatile compound BinBase mass spectral database. BMC Bioinformatics. 2011;12:321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [93].Shevchenko A, Tomas H, Havlis J, et al.. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc. 2006;1:2856–2860. [DOI] [PubMed] [Google Scholar]
  • [94].Santos AL, Abreu CM, Alviano CS, et al.. Use of proteolytic enzymes as an additional tool for trypanosomatid identification. Parasitology. 2005;130:79–88. [DOI] [PubMed] [Google Scholar]
  • [95].Abboud N, et al.. A requirement for FcgammaR in antibody-mediated bacterial toxin neutralization. J Exp Med. 2010;207:2395–2405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [96].Wu CA, Yang YW. Induction of cell death by saponin and antigen delivery. Pharm Res. 2004;21:271–277. [DOI] [PubMed] [Google Scholar]
  • [97].Jamur MC, Oliver C. Permeabilization of cell membranes. Methods Mol Biol. 2010;588:63–66. [DOI] [PubMed] [Google Scholar]
  • [98].Arqués O, Chicote I, Tenbaum S, et al.. Standardized Relative Quantification of Immunofluorescence Tissue Staining. Protocol Exchange. 2012. [Google Scholar]
  • [99].Abramoff MD, Magalhaes PJ, Ram SJ. Image Processing with image J. Biophoton Int. 2004. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1451184.zip

Articles from Virulence are provided here courtesy of Taylor & Francis

RESOURCES